Anaplastic Oligodendroglioma (AO) Completed Phase 2 Trials for Vincristine (DB00541)
Also known as: Anaplastic Oligodendroglioma / Anaplastic Oligodendrogliomas / Malignant oligodendroglioma / Oligodendroglioma, anaplastic (morphologic abnormality) / Oligodendroglioma malignant
Indication | Status | Phase |
---|---|---|
DBCOND0052374 (Anaplastic Oligodendroglioma (AO)) | Completed | 2 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT02684058 | Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors | Treatment |